Literature DB >> 19401393

Hypoxia increases macrophage motility, possibly by decreasing the heparan sulfate proteoglycan biosynthesis.

Annika Asplund1, Gunnel Ostergren-Lundén, Germán Camejo, Pia Stillemark-Billton, Göran Bondjers.   

Abstract

Macrophages are recruited and retained in hypoxic sites in atherosclerotic lesions and tumors. Furthermore, macrophages are suggested to be a major source of HSPG synthesis in atherosclerotic lesions. HSPG are, among other things, known to regulate cell motility, cell adhesion, and receptor interaction. The aim of this study was to investigate the effect of hypoxia on HSPG expression and macrophage motility. We also explored the potential regulation of HSPG by the transcription factor HIF-1alpha. The nondirected cell motility was increased in HMDM after 24 h exposure to hypoxia (0.5% O(2)) compared with normal cell culture condition (21% O(2)). Enzymatic degradation of HS GAG further increased the motility of the HMDM in hypoxia, indicating a role of reduced cell-associated HSPG in the increased HMDM motility. HMDM exposed to 24 h of hypoxia had lower mRNA expressions of syndecan-1 and -4 compared with cells exposed to normal cell culture conditions. Protein levels of syndecan-1 were also decreased significantly in response to hypoxia, and cells subjected to hypoxia had lower mRNA expression for key enzymes involved in HS biosynthesis. In addition, hypoxia was found to reduce the relative content of HS GAG. Transfecting THP-1 cells with siHIF-1alpha indicated that this transcription factor was not involved in the hypoxia-induced modifications of HSPG expression. Given the documented multiple functions of HSPG in macrophage behavior, the hypoxia-induced modifications of HSPG may be of relevance for the development of atherosclerotic lesions and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401393     DOI: 10.1189/jlb.0908536

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.

Authors:  Jianru Wang; Dessislava Markova; D Greg Anderson; Zhaomin Zheng; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

Review 2.  Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.

Authors:  Inkyung Kang; Mary Y Chang; Thomas N Wight; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

3.  Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia.

Authors:  Monique Fangradt; Martin Hahne; Timo Gaber; Cindy Strehl; Roman Rauch; Paula Hoff; Max Löhning; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2012-08-07       Impact factor: 5.156

Review 4.  Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease.

Authors:  Gan-lin Zhang; Xiao Zhang; Xiao-min Wang; Jin-Ping Li
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

Review 5.  Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.

Authors:  Mohamed R Akl; Poonam Nagpal; Nehad M Ayoub; Sathyen A Prabhu; Matthew Gliksman; Betty Tai; Ahmet Hatipoglu; Andre Goy; K Stephen Suh
Journal:  Oncotarget       Date:  2015-10-06

6.  Hypoxia Modulates the Response of Mast Cells to Staphylococcus aureus Infection.

Authors:  Helene Möllerherm; Katja Branitzki-Heinemann; Graham Brogden; Ayssar A Elamin; Wulf Oehlmann; Herbert Fuhrmann; Mahavir Singh; Hassan Y Naim; Maren von Köckritz-Blickwede
Journal:  Front Immunol       Date:  2017-05-11       Impact factor: 7.561

7.  Macrophages bind LDL using heparan sulfate and the perlecan protein core.

Authors:  Chun-Yi Ng; John M Whitelock; Helen Williams; Ha Na Kim; Heather J Medbury; Megan S Lord
Journal:  J Biol Chem       Date:  2021-03-05       Impact factor: 5.157

Review 8.  Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.

Authors:  Thomas N Wight; Inkyung Kang; Stephen P Evanko; Ingrid A Harten; Mary Y Chang; Oliver M T Pearce; Carys E Allen; Charles W Frevert
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

Review 9.  The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives.

Authors:  Noemi Veraldi; Nawel Zouggari; Ariane de Agostini
Journal:  Molecules       Date:  2020-01-17       Impact factor: 4.411

10.  Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE-/- Mice.

Authors:  Elena I Leonova; Elena S Sadovnikova; Elvira R Shaykhutdinova; Oxana V Galzitskaya; Arkady N Murashev; Alexandr S Solonin
Journal:  Open Biochem J       Date:  2017-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.